Token导航 LogoToken导航TokenDH.com
研究检索需要联网github未标认证来源可访问许可证需确认审计提醒

tooluniverse-disease-research工具宇宙疾病研究

Agent Skill

tooluniverse-disease-research 用于查找、检索和筛选相关信息,适合在 Codex、Claude、Cursor、Gemini CLI 中需要根据关键词、任务场景或来源线索快速定位候选结果时使用。可结合来源仓库、安装命令和原始 README 继续核验具体用法。安装前建议确认权限范围、维护状态,以及是否会触发联网、命令执行或文件读写。

总安装

5,704

周安装

233

GitHub Stars

1,269

下载量

1,827
CodexClaudeCursorGemini CLI

安装说明

本站只整理中文说明和来源信息,不托管安装包,也不代用户安装。

GitHub

来源数

2

许可证

unknown

最后核验

2026-05-01

来源状态

来源可访问

安装方式

通过对话安装

复制提示词发给支持本地命令或 Skills 的 AI 助手,先确认命令和权限,再让它执行。

请帮我安装这个 Agent Skill:tooluniverse-disease-research(工具宇宙疾病研究)
来源仓库:https://github.com/mims-harvard/tooluniverse
仓库路径:skills/tooluniverse-disease-research
安装命令:
npx skills add https://github.com/mims-harvard/tooluniverse --skill tooluniverse-disease-research
安装前请先检查当前环境是否支持对应 CLI,并向我确认将要执行的命令、安装目录、联网范围和文件读写权限;确认后再执行。

命令行安装

复制命令到本机终端执行。该命令会通过 npx skills 从第三方来源获取 Skill;本站只展示命令,不托管安装包,也不自动执行。

skills.shnpx skills
npx skills add https://github.com/mims-harvard/tooluniverse --skill tooluniverse-disease-research

简介

tooluniverse-disease-research 用于查找、检索和筛选相关信息,适合在 Codex、Claude、Cursor、Gemini CLI 中快速定位候选结果。

  • 它支持基于关键词、任务场景或来源线索进行信息匹配与过滤,适用于疾病研究类检索需求。
  • 通过 npx skills add 命令从指定 GitHub 仓库安装,需结合原始 README 了解具体调用方式。
  • 安装前建议确认权限范围、维护状态,以及是否会触发联网、命令执行或文件读写操作。
  • 可配合宿主环境中的其他工具链使用,提升信息获取效率与准确性。

SKILL.md

ToolUniverse Disease Research

Generate a comprehensive disease research report with full source citations. The report is created as a markdown file and progressively updated during research.

IMPORTANT: Always use English disease names and search terms in tool calls. Respond in the user's language.


LOOK UP, DON'T GUESS

When asked about a disease, query Orphanet/OMIM/DisGeNET FIRST. Don't rely on memory for prevalence, genetics, or treatment — these change over time. When you're not sure about a fact, your first instinct should be to SEARCH for it using tools, not to reason harder from memory.


When to Use

  • User asks about any disease, syndrome, or medical condition
  • Needs comprehensive disease intelligence or a detailed research report
  • Asks "what do we know about [disease]?"

Core Workflow: Report-First Approach

DO NOT show the search process to the user. Instead:

  1. Create report file first - Initialize {disease_name}_research_report.md
  2. Research each dimension - Use all relevant tools
  3. Update report progressively - Write findings after each dimension
  4. Include citations - Every fact must reference its source tool

Disease Mechanism Reasoning

When synthesizing disease etiology, trace the full pathogenic cascade:

  1. Genetic basis - Which variants (rare or common) confer risk, and in which genes?
  2. Molecular mechanism - How do those variants alter protein function, expression, or regulation?
  3. Cellular effect - What downstream cellular processes are disrupted (signaling, metabolism, stress response)?
  4. Tissue/organ manifestation - How does cellular dysfunction present as organ-level pathology?

This chain structures the Genetic & Molecular Basis (Section 3) and Biological Pathways (Section 5) sections.


10 Research Dimensions

DimSectionKey Tools
1Identity & ClassificationOSL_get_efo_id_by_disease_name, ols_search_efo_terms, ols_get_efo_term, umls_search_concepts, icd_search_codes, snomed_search_concepts
2Clinical PresentationOpenTargets phenotypes, HPO lookup, MedlinePlus
3Genetic & Molecular BasisOpenTargets targets, ClinVar variants, GWAS associations, gnomAD
4Treatment LandscapeOpenTargets drugs, clinical trials, GtoPdb
5Biological PathwaysReactome pathways, humanbase_ppi_analysis, GTEx expression, HPA
6Epidemiology & LiteraturePubMed, OpenAlex, Europe PMC, Semantic Scholar
7Similar DiseasesOpenTargets similar entities
8Cancer-Specific (if applicable)CIViC genes/variants/therapies
9PharmacologyGtoPdb targets/interactions/ligands
10Drug SafetyOpenTargets warnings, clinical trial AEs, FAERS

See: tool_usage_details.md for complete tool calls per section.


Report Template

Create this file structure at the start:

# Disease Research Report: {Disease Name}

**Report Generated**: {date}
**Disease Identifiers**: (to be filled)

---

## Executive Summary
(Brief 3-5 sentence overview - fill after all research complete)

---

## 1. Disease Identity & Classification
### Ontology Identifiers
| System | ID | Source |

### Synonyms & Alternative Names
### Disease Hierarchy

---

## 2. Clinical Presentation
### Phenotypes (HPO)
| HPO ID | Phenotype | Description | Source |

### Symptoms & Signs
### Diagnostic Criteria

---

## 3. Genetic & Molecular Basis
### Associated Genes
| Gene | Score | Ensembl ID | Evidence | Source |

### GWAS Associations
| SNP | P-value | Odds Ratio | Study | Source |

### Pathogenic Variants (ClinVar)

---

## 4. Treatment Landscape
### Approved Drugs
| Drug | ChEMBL ID | Mechanism | Phase | Target | Source |

### Clinical Trials
| NCT ID | Title | Phase | Status | Source |

---

## 5. Biological Pathways & Mechanisms

## 6. Epidemiology & Risk Factors

## 7. Literature & Research Activity

## 8. Similar Diseases & Comorbidities

## 9. Cancer-Specific Information (if applicable)

## 10. Drug Safety & Adverse Events

---

## References
### Tools Used
| # | Tool | Parameters | Section | Items Retrieved |

Citation Format

Every piece of data MUST include its source:

In tables: Add a Source column with tool name In lists: - Finding [Source: tool_name] In prose: (Source: tool_name, query: "...") References section: Complete tool usage log with parameters


Progressive Update Pattern

# After each dimension's research:
# 1. Read current report
# 2. Replace placeholder with formatted content
# 3. Write back immediately
# 4. Continue to next dimension

Evidence Grading & Interpretation

Every finding in the report should be graded:

GradeCriteriaExample
T1 (Strong)Replicated genetic evidence (GWAS, rare variants), FDA-approved therapyBRCA1 → breast cancer; trastuzumab for HER2+
T2 (Moderate)Single genetic study, phase II+ trial data, strong biological evidenceFOXO3 → longevity (centenarian studies)
T3 (Association)Observational data, gene expression changes, pathway membershipIL-6 elevated in Alzheimer's CSF
T4 (Computational)Network proximity, text mining, predicted associationsDisGeNET text-mined gene-disease link

Synthesis Questions (answer in Executive Summary)

After collecting data from all 10 dimensions, the report MUST answer:

  1. What causes this disease? Summarize the genetic architecture (monogenic vs polygenic, key loci, penetrance)
  2. What are the therapeutic options? Ranked by evidence level and approval status
  3. What biomarkers exist? For diagnosis, prognosis, and treatment selection
  4. What's the unmet need? What aspects lack effective treatment or understanding?
  5. What are the active research frontiers? Based on clinical trials and recent publications

Interpreting Cross-Database Concordance

When multiple databases provide different data for the same disease:

  • OpenTargets + DisGeNET + OMIM agree on a gene: T1 evidence — high confidence
  • Only OpenTargets reports an association: Check the datasource scores — genetic_association > literature > animal_model
  • DisGeNET score > 0.5 but not in OpenTargets: May be text-mined; verify with PubMed
  • Gene in GWAS but not OMIM: Likely a complex disease susceptibility locus, not Mendelian

Handling Conflicting Data

ConflictResolution
Different prevalence estimates across sourcesReport range; note the most recent/largest study
Drug approved in one country but not anotherNote regulatory status per region
Gene-disease association in one DB but absent in anotherGrade by evidence type; text-mining alone is T4
Clinical trial results contradict label indicationsThe trial result is newer evidence; note both

Final Report Quality Checklist

  • All 10 sections have content (or marked "No data available")
  • Every data point has a source citation
  • Executive summary reflects key findings
  • References section lists all tools used
  • Tables properly formatted
  • No placeholder text remains

Expected Output Scale

For a well-studied disease (e.g., Alzheimer's), the final report should include:

  • 5+ ontology IDs, 10+ synonyms, disease hierarchy
  • 20+ phenotypes with HPO IDs
  • 50+ genes, 30+ GWAS associations, 100+ ClinVar variants
  • 20+ drugs, 50+ clinical trials
  • 10+ pathways, PPI network, expression data
  • 100+ publications
  • 15+ similar diseases
  • Drug warnings and adverse events

Total: 500+ individual data points, each with source citation.


Cross-Skill References

For rare disease differential diagnosis, run: python3 skills/tooluniverse-rare-disease-diagnosis/scripts/clinical_patterns.py --type differential --symptoms 'symptom1,symptom2'


Reference Files

适合场景

01

用户想查找某类 Agent Skill 时

02

需要根据任务场景推荐可安装能力包时

03

需要对比不同来源的安装命令和来源信息时

能力概览

能力 1

按任务关键词查找相关 Skills

能力 2

展示可复制的安装命令

能力 3

保留来源站点、仓库和原始说明,方便继续核验

能力 4

展示第三方安全扫描或审计结果

安装后应在对应宿主中按原始 README 的触发条件使用;具体调用方式请以来源页面和 README 为准。

平台分布

Codex

34.69%
按下载量换算634

Claude

28.54%
按下载量换算521

Cursor

19.17%
按下载量换算350

Gemini CLI

8.84%
按下载量换算162

安全审计

Gen Agent Trust Hub

通过

Socket

通过

Snyk

可疑

权限和风险

需要联网

该 Skill 可能需要联网访问来源站点、仓库或外部 API;具体网络访问范围需要结合源码和 README 复核。

安装前确认

本站仅展示第三方公开信息,不托管安装包,不提供自动安装或运行环境。安装前应自行审查源码、依赖和命令行为。来源安全扫描存在 warning/failed 结果,不能写成本站确认安全。当前只有一个来源,正式发布前建议补源仓库或其他目录站核验。

来源信息

继续浏览同类 Skills